804
Views
21
CrossRef citations to date
0
Altmetric
Research Article

In vitro interference of Momordica charantia in the resistance to aminoglycosides

, , , &
Pages 1056-1059 | Received 07 May 2008, Accepted 22 Aug 2008, Published online: 19 Oct 2009
 

Abstract

In this study, the ethanol extract of Momordica charantia L. (EEMC) (Cucurbitaceae) was tested for its antimicrobial activity against strains of Escherichia coli. The growth of two E. coli strains tested was not inhibited by the extract. The MIC and MBC values were ≥ 1 mg/mL for both strains of E. coli used. A synergistic effect between this extract and aminoglycosides was demonstrated. Similarly, a synergistic effect was observed of chlorpromazine on kanamycin and amikacin, indicating the involvement of an efflux system in the resistance to these aminoglycosides. The checkerboard method with combinations of aminoglycosides and EEMC demonstrated synergism with kanamycin and an additive effect with amikacin and neomycin. It is therefore suggested that extracts from M. charantia could be used as a source of plant-derived natural products with resistance-modifying activity. This is the first report about the modifying antibiotic activity of Momordica charantia, constituting a new weapon against bacterial resistance to antibiotics, as with chlorpromazine.

Declaration of interest: The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.